Starpharma reports strong Q2 FY25 progress 🌟 FDA feedback boosts DEP SN38 potential for Fast Track approval

🚀 VivaGel BV launches in the Middle East soon, and Viraleze sales grow 💻💼 2025 looks bright with 20.3 million dollars cash on hand 💡

#Biotech #Healthcare #Innovation
#Biotech #Healthcare #Innovation